Hand Foot Syndrome Market Report 2026

Hand Foot Syndrome Market Overview

• Hand Foot Syndrome market size has reached to $0.52 billion in 2025 • Expected to grow to $0.7 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Rising Cancer Cases Driving The Growth Of The Market Due To Increasing Chemotherapy Usage • Asia-Pacific was the largest region in 2025.

What Is Covered Under Hand Foot Syndrome Market?

Hand foot syndrome known as palmar-plantar erythrodysesthesia, is a condition caused by chemotherapy or certain medications. It results in redness, swelling, pain, and peeling on the palms of the hands and soles of the feet. In severe cases, blisters and ulcerations may form, affecting daily activities. The main treatments for hand foot syndrome are systemic and topical treatment. Systemic treatments involve medications that act throughout the body to alleviate symptoms and prevent complications. These treatments have applications across various fields, including oncology, dermatology, and others, and are used in settings such as hospitals, clinics, and homecare environments.

What Is The Hand Foot Syndrome Market Growth Forecast?

The hand foot syndrome market size is expected to see strong growth in the next few years. It will grow to $0.7 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing demand for supportive oncology care solutions, rising investments in dermatology-oncology crossover treatments, expansion of homecare-based symptom management, growing focus on improving patient quality of life, increasing development of advanced topical formulations. Major trends in the forecast period include increasing development of targeted topical therapies, rising focus on patient-centric symptom management, growing adoption of combination treatment approaches, expansion of supportive dermatology care protocols, enhanced emphasis on treatment compliance.

Global Hand Foot Syndrome Market Segmentation

1) By Treatment: Systemic Treatment, Topical Treatment 2) By Application: Oncology, Dermatology, Other Applications 3) By End-User: Hospitals, Clinics, Homecare Settings Subsegments: 1) By Systemic Treatment: Corticosteroids, Analgesics, Anti-Inflammatory Drugs 2) By Topical Treatment: Urea-Based Creams, Corticosteroid Creams, Moisturizers, Cooling Gels

What Are The Drivers Of The Hand Foot Syndrome Market?

The increasing incidence of cancer is expected to fuel the growth of the hand foot syndrome market going forward. Cancer is a disease characterized by uncontrolled cell growth and spread to other parts of the body. The rising cancer cases are driven by aging populations, lifestyle changes, environmental factors, and improved detection methods. The increasing incidence of cancer leads to higher chemotherapy usage, which in turn raises the prevalence of hand-foot syndrome as a treatment-related side effect. For instance, in August 2024, Macmillan Cancer Support, a UK-based charitable organization dedicated to assisting cancer patients, reported that over 3 million people in the UK were living with cancer. This number is projected to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing incidence of cancer will drive the hand foot syndrome industry. The increasing demand for personalized treatments is expected to propel the growth of the hand foot syndrome market going forward. Personalized treatments are medical interventions tailored to an individual's specific genetic, environmental, and lifestyle factors to optimize effectiveness and minimize side effects. The demand for personalized treatments is rising due to advancements in genetic research, increased awareness of individualized healthcare, and the growing recognition that tailored therapies offer improved efficacy and fewer side effects compared to traditional one-size-fits-all approaches. Personalized treatments for hand-foot syndrome are used to tailor prevention and management strategies to an individual’s severity, symptoms, and treatment regimen, helping reduce discomfort while enabling continuation of cancer therapy. For instance, in February 2024, Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approved in 2022. Therefore, the increasing demand for personalized treatments is expected to drive the growth of the hand foot syndrome industry.

Key Players In The Global Hand Foot Syndrome Market

Major companies operating in the hand foot syndrome market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Fresenius Kabi AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., UCB Pharma SA, Eisai Co. Ltd.

What Are Latest Mergers And Acquisitions In The Hand Foot Syndrome Market?

In June 2024, AstraZeneca Plc, a UK-based pharmaceutical company, acquired Fusion Pharmaceuticals Inc. for $2.5 billion. This acquisition aims to enhance the oncology portfolio with advanced radiopharmaceuticals such as FPI-2265, strengthen R&D and manufacturing capabilities, and accelerate the shift to targeted cancer therapies while deepening its presence in Canada. Fusion Pharmaceuticals Inc. is a Canada-based biotechnology company that specializes in developing next-generation radiopharmaceuticals as precision medicines for oncology.

Regional Outlook

Asia-Pacific was the largest region in the hand food syndrome market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hand Foot Syndrome Market?

The hand foot syndrome market consists of revenues earned by entities providing services such as treatments, therapies, and supportive care services for managing symptoms and complications of the condition. The market value includes the value of related goods sold by the service provider or included within the service offering. The hand foot syndrome market also includes sales of pharmaceutical drugs, topical treatments, and medical devices used to alleviate symptoms and manage the condition. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hand Foot Syndrome Market Report 2026?

The hand foot syndrome market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hand foot syndrome industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.